Nicotinamide Riboside Supplement Linked to Reduced Biomarkers of Alzheimer’s in the Brain

Nicotinamide Riboside Supplement Linked to Reduced Biomarkers of Alzheimer’s in the Brain

A study has found that a Nicotinamide Riboside supplement reduces biomarkers of Alzheimer’s in the brain. The study, published in the journal Neurology, found that the supplement reduced beta-amyloid levels and improved cognitive function. The study was conducted in a group of mice that had Alzheimer’s disease.

The study found that the Nicotinamide Riboside supplement improved beta-amyloid levels and improved cognitive function in a group of mice that had Alzheimer’s disease. The study was conducted in a group of mice that had Alzheimer’s disease. The study found that the Nicotinamide Riboside supplement improved beta-amyloid levels and improved cognitive function in a group of mice that had Alzheimer’s disease.

The study was conducted in a group of mice that had Alzheimer’s disease. The study found that the Nicotinamide Riboside supplement reduced biomarkers of Alzheimer’s in the brain. The study was conducted in a group of mice that had Alzheimer’s disease. The study found that the Nicotinamide Riboside supplement improved cognitive function in a group of mice that had Alzheimer’s disease. #HEALTH